Trials / Completed
CompletedNCT05072938
Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
A Multi-center, Open-label, Randomized, Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 260 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy with Nizatidine Monotherapy in Patients with Gastritis
Detailed description
The purpose of this study is to compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy with Nizatidine Monotherapy in Patients with Gastritis. Anticipated result is to prove superiority of Rebamipide/Nizatidine combination therapy at 2 weeks compared to Nizatidine Monotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mucotra SR Tablet 150mg | Rebamipide/Nizatidine Combination Therapy |
| DRUG | Axid Capsule 150mg | Nizatidine Monotherapy |
Timeline
- Start date
- 2021-09-30
- Primary completion
- 2022-12-15
- Completion
- 2022-12-15
- First posted
- 2021-10-11
- Last updated
- 2024-07-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05072938. Inclusion in this directory is not an endorsement.